美国FDA生物制品紫皮书数据库（U.S. FDA Purple Book: Database of Licensed Biological Products）- 药物在线

商品名	申请号	产品号	BLA类型	非专利名称	剂型	给药途径	规格/剂量	产品形式	批准日期	申请人	市场状态	许可证状态	参考产品非专利名称	参考产品专利名称
Monoclate, Monoclate-P	103953	002	351(a)	Antihemophilic Factor (Human)	For Injection	Intravenous	1000IU	Vial	2003/05/14	CSL Behring LLC	Disc	Voluntarily Revoked		N/A
Monoclate, Monoclate-P	103953	003	351(a)	Antihemophilic Factor (Human)	For Injection	Intravenous	250IU	Vial	2003/05/14	CSL Behring LLC	Disc	Voluntarily Revoked		N/A
Aldurazyme	125058	001	351(a)	laronidase	Injection	Intravenous	2.9MG/5ML (0.58MG/ML)	Single-Dose Vial	2003/04/30	BioMarin Pharmaceutical Inc.	Rx	Licensed	N/A	N/A
Fabrazyme	103979	001	351(a)	agalsidase beta	For Injection	Intravenous	35MG	Single-Dose Vial	2003/04/24	Genzyme Corporation	Rx	Licensed	N/A	N/A
Iprivask	021271	001	351(a)	desirudin	For Injection	Subcutaneous	15MG	Single-Dose Vial	2003/04/04	Bausch Health US, LLC	Disc	Voluntarily Revoked	N/A	N/A
Somavert	021106	001	351(a)	pegvisomant	For Injection	Subcutaneous	10MG	Single-Dose Vial	2003/03/25	Pharmacia & Upjohn Company LLC	Rx	Licensed	N/A	N/A
Somavert	021106	002	351(a)	pegvisomant	For Injection	Subcutaneous	15MG	Single-Dose Vial	2003/03/25	Pharmacia & Upjohn Company LLC	Rx	Licensed	N/A	N/A
Somavert	021106	003	351(a)	pegvisomant	For Injection	Subcutaneous	20MG	Single-Dose Vial	2003/03/25	Pharmacia & Upjohn Company LLC	Rx	Licensed	N/A	N/A
Crosseal, Evicel	125010	001	351(a)	Fibrin Sealant (Human)	Spray	Topical	5ML	Single-Dose Vial	2003/03/21	Omrix Biopharmaceuticals Ltd	Disc	Voluntarily Revoked		N/A
Crosseal, Evicel	125010	002	351(a)	Fibrin Sealant (Human)	Spray	Topical	1ML	Single-Dose Vial	2003/03/21	Omrix Biopharmaceuticals Ltd	Disc	Voluntarily Revoked		N/A
Crosseal, Evicel	125010	003	351(a)	Fibrin Sealant (Human)	Spray	Topical	2ML	Single-Dose Vial	2003/03/21	Omrix Biopharmaceuticals Ltd	Disc	Voluntarily Revoked		N/A
Amevive	125036	001	351(a)	alefacept	For Injection	Intravenous	7.5MG	Single-Dose Vial	2003/01/30	Astellas Pharma US, Inc.	Disc	Voluntarily Revoked	N/A	N/A
Amevive	125036	002	351(a)	alefacept	For Injection	Intramuscular	15MG	Single-Dose Vial	2003/01/30	Astellas Pharma US, Inc.	Disc	Voluntarily Revoked	N/A	N/A
Simulect	103764	002	351(a)	basiliximab	For Injection	Intravenous	10MG	Single-Dose Vial	2003/01/02	Novartis Pharmaceuticals Corporation	Rx	Licensed	N/A	N/A
Humira	125057	001	351(a)	adalimumab	Injection	Subcutaneous	40MG/0.8ML	Autoinjector	2002/12/31	AbbVie Inc.	Rx	Licensed	N/A	N/A
Humira	125057	002	351(a)	adalimumab	Injection	Subcutaneous	40MG/0.8ML	Pre-Filled Syringe	2002/12/31	AbbVie Inc.	Rx	Licensed	N/A	N/A
Aralast, Aralast Np	125039	001	351(a)	Alpha-1-Proteinase Inhibitor (Human)	For Injection	Intravenous	0.5G	Single-Dose Vial	2002/12/23	Takeda Pharmaceuticals U.S.A., Inc.	Rx	Licensed		N/A
Aralast, Aralast Np	125039	002	351(a)	Alpha-1-Proteinase Inhibitor (Human)	For Injection	Intravenous	1.0G	Single-Dose Vial	2002/12/23	Takeda Pharmaceuticals U.S.A., Inc.	Rx	Licensed		N/A
Aranesp	103951	014	351(a)	darbepoetin alpha	Injection	Intravenous, Subcutaneous	60MCG/0.3ML	Pre-Filled Syringe	2002/12/17	Amgen Inc.	Disc	Licensed	N/A	N/A
Aranesp	103951	015	351(a)	darbepoetin alpha	Injection	Intravenous, Subcutaneous	100MCG/0.5ML	Pre-Filled Syringe	2002/12/17	Amgen Inc.	Disc	Licensed	N/A	N/A

药品商品名或专利药名Proprietary (Brand) Name
药品通用名或非专利名称Nonproprietary (Proper) Name
药品申请号BLA Number
产品号Product Number
剂型Dosage Form
给药途径Route of Administration
产品形式Product Presentation
药品规格或剂量Strength
药品注册申请人Applicant
参考产品非专利名称Reference Product Proper Name
参考产品专利名称Reference Product Proprietary Name
BLA类型BLA Type
药品的市场状态Marketing Status
许可证号License Number
许可证状态Licensure
产品批准日期Approval Date	-